Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer
David D‘Andrea, Peter C. Black, Homayoun Zargar, Kamran Zargar‐Shoshtari, Sonja Zehetmayer, Adrian Fairey, Laura S. Mertens, Colin P. Dinney, Maria Carmen Mir, Laura-Maria Krabbe, Michael S. Cookson, Niels-Erik Jacobsen, Jeffrey S. Montgomery, Nikhil Vasdev, Evan Y. Yu, Évanguelos Xylinas, Nicholas Campain, Wassim Kassouf, Marc Dall’Era, Jo-An Seah, Cesar E. Ercole, Simon Horenblas, Srikala S. Sridhar, John McGrath, Jonathan Aning, Jonathan L. Wright, Andrew C. Thorpe, Todd M. Morgan, Jeffrey M. Holzbeierlein, Trinity J. Bivalacqua, Scott North, Daniel A. Barocas, Yair Lotan, Petros Grivas, Andrew J. Stephenson, Jay B. Shah, Bas W. van Rhijn, Siamak Daneshmand, Philippe E. Spiess, Shahrokh F. Shariat
Topics & Concepts
Hazard ratioMedicineConfidence intervalBladder cancerProportional hazards modelInternal medicineLogistic regressionCystectomyOncologyMenopauseStage (stratigraphy)Odds ratioCancerChemotherapyGynecologyBiologyPaleontologyBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesProstate Cancer Diagnosis and Treatment